Grup Bàsic i Clínic d'Immunologia i Endocrinologia
2009 SGR 805
![Foto de Grup Bàsic i Clínic d'Immunologia i Endocrinologia](/img/grupo.png)
![Foto de Universitat de Barcelona](/img/noimage_org.png)
Universitat de Barcelona
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Universitat de Barcelona (31)
2023
-
NOD mouse dorsal root ganglia display morphological and gene expression defects before and during autoimmune diabetes development
Frontiers in Endocrinology, Vol. 14
2021
2019
-
B-Lymphocyte Phenotype Determines T-Lymphocyte Subset Differentiation in Autoimmune Diabetes
Frontiers in immunology, Vol. 10, pp. 1732
2018
-
Phosphatidylserine-liposomes promote tolerogenic features on dendritic cells in human type 1 diabetes by apoptotic mimicry
Frontiers in Immunology, Vol. 9, Núm. FEB
-
Treatment of T1D via optimized expansion of antigen-specific Tregs induced by IL-2/anti-IL-2 monoclonal antibody complexes and peptide/MHC tetramers
Scientific Reports, Vol. 8, Núm. 1
2016
-
B-lymphocytes expressing an Ig specificity recognizing the pancreatic β-cell autoantigen peripherin are potent contributors to type 1 diabetes development in NOD mice
Diabetes, Vol. 65, Núm. 7, pp. 1977-1987
-
LoVo colon cancer cells resistant to oxaliplatin overexpress c-MET and VEGFR-1 and respond to VEGF with dephosphorylation of c-MET
Molecular Carcinogenesis, Vol. 55, Núm. 5, pp. 411-419
2015
-
Use of autoantigen-loaded phosphatidylserine-liposomes to arrest autoimmunity in type 1 diabetes
PLoS ONE, Vol. 10, Núm. 6
2014
-
Cyclin D3 promotes pancreatic β-cell fitness and viability in a cell cycle-independent manner and is targeted in autoimmune diabetes
Proceedings of the National Academy of Sciences of the United States of America, Vol. 111, Núm. 33
-
In vivo detection of peripherin-specific autoreactive B cells during type 1 diabetes pathogenesis
Journal of Immunology, Vol. 192, Núm. 7, pp. 3080-3090
2013
-
Cholera toxin subunit B peptide fusion proteins reveal impaired oral tolerance induction in diabetes-prone but not in diabetes-resistant mice
European Journal of Immunology, Vol. 43, Núm. 11, pp. 2969-2979
2012
-
The sole presence of CDK4 is not a solid criterion for discriminating between tumor and healthy pancreatic tissues
International Journal of Cancer
2011
-
In vivo diabetogenic action of CD4+ T lymphocytes requires Fas expression and is independent of IL-1 and IL-18
European Journal of Immunology, Vol. 41, Núm. 5, pp. 1344-1351
-
Targeting of a T cell agonist peptide to lysosomes by DNA vaccination induces tolerance in the nonobese diabetic mouse
Journal of Immunology, Vol. 186, Núm. 7, pp. 4078-4087
2010
-
Dendritic cells pulsed with antigen-specific apoptotic bodies prevent experimental type 1 diabetes
Clinical and Experimental Immunology, Vol. 160, Núm. 2, pp. 207-214
-
Gene expression profiles for the human pancreas and purified islets in Type 1 diabetes: New findings at clinical onset and in long-standing diabetes
Clinical and Experimental Immunology, Vol. 159, Núm. 1, pp. 23-44
2008
-
Anti-peripherin B lymphocytes are positively selected during diabetogenesis
Molecular Immunology, Vol. 45, Núm. 11, pp. 3152-3162
-
Cyclin-dependent kinase 4 hyperactivity promotes autoreactivity in the immune system but protects pancreatic β cell mass from autoimmune destruction in the nonobese diabetic mouse model
Journal of Immunology, Vol. 180, Núm. 2, pp. 1189-1198
2004
-
Pancreatic islets from cyclin-dependent kinase 4/R24C (Cdk4) knockin mice have significantly increased beta cell mass and are physiologically functional, indicating that Cdk4 is a potential target for pancreatic beta cell mass regeneration in Type 1 diabetes
Diabetologia, Vol. 47, Núm. 4, pp. 686-694
-
Role of L-selectin in the development of autoimmune diabetes in non-obese diabetic mice
International Immunology, Vol. 16, Núm. 2, pp. 257-264